Associations of pregnancy characteristics with maternal and cord steroid hormones, angiogenic factors, and insulin-like growth factor axis

Cancer Causes and Control

Volumn 22, Issue 11, 2011, Pages 1587-1595

  Faupel Badger, Jessica M ^a   Wang, Yuping ^b   Karumanchi, S Ananth ^c   Stanczyk, Frank ^d   Pollak, Michael ^e   McElrath, Thomas ^f   Hoover, Robert N ^a   Troisi, Rebecca ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Louisiana State University School of Medicine Shreveport   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e MCGILL UNIVERSITY   (Canada)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

African American; Angiogenic factors; IGF; Leptin; Prolactin

Indexed keywords

ANDROSTENEDIONE; ANGIOGENIC FACTOR; C PEPTIDE; CD135 ANTIGEN; ENDOGLIN; ESTRADIOL; ESTRIOL; LEPTIN; PLACENTAL GROWTH FACTOR; PROGESTERONE; PROLACTIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; STEROID HORMONE; TESTOSTERONE;

ADULT; AFRICAN AMERICAN; ARTICLE; BIOLOGICAL ACTIVITY; CANCER INCIDENCE; CANCER RISK; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME BLOOD LEVEL; FEMALE; FETUS; FETUS CIRCULATION; HORMONE BLOOD LEVEL; HUMAN; LINEAR REGRESSION ANALYSIS; MATERNAL BLOOD; PREGNANCY; PRIORITY JOURNAL; PROGENY; PROTEIN BLOOD LEVEL; SEX DIFFERENCE; UMBILICAL CORD BLOOD;

ADULT; ANGIOGENESIS INDUCING AGENTS; FEMALE; FETAL BLOOD; GONADAL STEROID HORMONES; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LEPTIN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; YOUNG ADULT;

EID: 82955163948     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-011-9835-3     Document Type: Article

References (44)

1. Randhawa RS (2008) The insulin-like growth factor system and fetal growth restrictionn. Pediatr Endocrinol Rev 6:235-240
2. Troisi R, Potischman N, Roberts JM, Ness R, Crombleholme W, Lykins D et al (2003) Maternal serum oestrogen and androgen concentrations in preeclamptic and uncomplicated pregnancies. Int J Epidemiol 32:455-460 (Pubitemid 36764107)
3. Young BC, Levine RJ, Karumanchi SA (2010) Pathogenesis of preeclampsia. Annu Rev Pathol 5:173-192
4. Acromite MT, Mantzoros CS, Leach RE, Hurwitz J, Dorey LG (1999) Androgens in preeclampsia. Am J Obstet Gynecol 180:60-63 (Pubitemid 29088390)
5. Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP et al (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355:992-1005 (Pubitemid 44343543)
6. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF et al (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350:672-683 (Pubitemid 38364626)
7. Levine RJ, Qian C, Maynard SE, Yu KF, Epstein FH, Karumanchi SA (2006) Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. Am J Obstet Gynecol 194:1034-1041
8. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S et al (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111:649-658 (Pubitemid 36278583)
9. Rana S, Karumanchi SA, Levine RJ, Venkatesha S, Rauh-Hain JA, Tamez H et al (2007) Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension 50:137-142 (Pubitemid 46986022)
10. Romero R, Nien JK, Espinoza J, Todem D, Fu W, Chung H et al (2008) A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med 21:9-23
11. Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR (2005) Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 122:33-39 (Pubitemid 41265677)
12. Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP et al (2004) First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab 89:770-775 (Pubitemid 38269892)
13. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM et al (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12:642-649 (Pubitemid 43865232)
14. Salamalekis E, Bakas P, Vitoratos N, Eleptheriadis M, Creatsas G (2006) Androgen levels in the third trimester of pregnancy in patients with preeclampsia. Eur J Obstet Gynecol Reprod Biol 126:16-19
15. Barker DJ (1995) Fetal origins of coronary heart disease. BMJ 311:171-174
16. Barker DJ (2007) The origins of the developmental origins theory. J Intern Med 261:412-417 (Pubitemid 46587729)
17. Troisi R, Potischman N, Hoover RN (2007) Exploring the underlying hormonal mechanisms of prenatal risk factors for breast cancer: A review and commentary. Cancer Epidemiol Biomarkers Prev 16:1700-1712 (Pubitemid 47450497)
18. Ekbom A (1998) Growing evidence that several human cancers may originate in utero. Semin Cancer Biol 8:237-244 (Pubitemid 28550381)
19. Henderson BE, Bernstein L, Ross RK, Depue RH, Judd HL (1988) The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring. Br J Cancer 57:216-218 (Pubitemid 18085409)
20. Trichopoulos D (1990) Hypothesis: does breast cancer originate in utero? Lancet 335:939-940
21. Albrecht ED, Babischkin JS, Lidor Y, Anderson LD, Udoff LC, Pepe GJ (2003) Effect of estrogen on angiogenesis in co-cultures of human endometrial cells and microvascular endothelial cells. Hum Reprod 18:2039-2047 (Pubitemid 37265063)
22. Albrecht ED, Pepe GJ (2003) Steroid hormone regulation of angiogenesis in the primate endometrium. Front Biosci 8:d416-d429 (Pubitemid 38943200)
23. Dabrosin C (2005) Sex steroid regulation of angiogenesis in breast tissue. Angiogenesis 8:127-136 (Pubitemid 41712842)
24. Hyder SM, Chiappetta C, Stancel GM (2000) Induction of the angiogenic factor VEGF in the uterus by the antiprogestin onapristone. Cancer Lett 156:101-107 (Pubitemid 30326773)
25. Hyder SM, Nawaz Z, Chiappetta C, Stancel GM (2000) Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res 60:3183-3190 (Pubitemid 30407915)
26. Shenoy V, Kanasaki K, Kalluri R (2010) Pre-eclampsia: connecting angiogenic and metabolic pathways. Trends Endocrinol Metab 21:529-536
27. Gingery A, Bahe EL, Gilbert JS (2009) Placental ischemia and breast cancer risk after preeclampsia: tying the knot. Expert Rev Anticancer Ther 9:671-681
28. Key T, Appleby P, Barnes I, Reeves G (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606-616 (Pubitemid 34498648)
29. Ray A, Cleary MP (2010) Leptin as a potential therapeutic target for breast cancer prevention and treatment. Expert Opin Ther Targets 14:443-451
30. Vona-Davis L, Rose DP (2009) Angiogenesis, adipokines and breast cancer. Cytokine Growth Factor Rev 20:193-201
31. Zhang J, Masciocchi M, Lewis D, Sun W, Liu A, Wang Y (2008) Placental anti-oxidant gene polymorphisms, enzyme activity, and oxidative stress in preeclampsia. Placenta 29:439-443
32. Goebelsmann AE, Bernstein GS, Gale JA, Kletzky OA, Nakamura RM, Coulson AH (eds) (1979) Serum gonadotropin, testosterone, estradiol and estrone levels prior to and following bilateral vasectomy. Academic Press, New York
33. Goebelsmann U, Horton R, Mestman JH, Arce JJ, Nagata Y, Nakamura RM et al (1973) Male pseudohermaphroditism due to testicular 17 -hydroxysteroid dehydrogenase deficiency. J Clin Endocrinol Metab 36:867-879
34. Probst-Hensch NM, Ingles SA, Diep AT, Haile RW, Stanczyk FZ, Kolonel LN et al (1999) Aromatase and breast cancer susceptibility. Endocr Relat Cancer 6:165-173 (Pubitemid 29260048)
35. Scott JZ, Stanczyk FZ, Goebelsmann U, Mishell DR Jr (1978) A double-antibody radioimmunoassay for serum progesterone using progesterone-3-(O-carboxymethyl) oximino-[125I]-iodo-histamine as radioligand. Steroids 31:393-405 (Pubitemid 9126236)
36. Katagiri H, Stanczyk FZ, Goebelsmann U (1974) Estriol in pregnancy. III. Development, comparison and use of specific antisera for rapid radioimmunoassay of unconjugated estriol in pregnancy plasma. Steroids 24:225-238
37. Troisi R, Potischman N, Roberts JM, Harger G, Markovic N, Cole B et al (2003) Correlation of serum hormone concentrations in maternal and umbilical cord samples. Cancer Epidemiol Biomarkers Prev 12:452-456 (Pubitemid 36578484)
38. Rohrmann S, Sutcliffe CG, Bienstock JL, Monsegue D, Akereyeni F, Bradwin G et al (2009) Racial variation in sex steroid hormones and the insulin-like growth factor axis in umbilical cord blood of male neonates. Cancer Epidemiol Biomarkers Prev 18:1484-1491
39. Potischman N, Troisi R, Thadhani R, Hoover RN, Dodd K, Davis WW et al (2005) Pregnancy hormone concentrations across ethnic groups: implications for later cancer risk. Cancer Epidemiol Biomarkers Prev 14:1514-1520 (Pubitemid 40807355)
40. Park SK, Kang D, McGlynn KA, Garcia-Closas M, Kim Y, Yoo KY et al (2008) Intrauterine environments and breast cancer risk: meta-analysis and systematic review. Breast Cancer Res 10:R8
41. Silva Idos S, De Stavola B, McCormack V (2008) Birth size and breast cancer risk: re-analysis of individual participant data from 32 studies. PLoS Med 5:e193
42. Xu X, Dailey AB, Peoples-Sheps M, Talbott EO, Li N, Roth J (2009) Birth weight as a risk factor for breast cancer: A metaanalysis of 18 epidemiological studies. J Womens Health (Larchmt) 18:1169-1178
43. Caughey RW, Michels KB (2009) Birth weight and childhood leukemia: A meta-analysis and review of the current evidence. Int J Cancer 124:2658-2670
44. Troisi R, Lagiou P, Trichopoulos D, Xu B, Chie L, Stanczyk FZ et al (2008) Cord serum estrogens, androgens, insulin-like growth factor-I, and insulin-like growth factor binding protein-3 in Chinese and U.S. Caucasian neonates. Cancer Epidemiol Biomarkers Prev 17:224-231 (Pubitemid 351196295)